{"rows":[{"id":5969,"title":"Open-label, Single-arm fMRI Study Evaluating the Effects of Psilocybin on Craving in Nicotine Dependence.","authors":"University of British Columbia","journal":"ClinicalTrials.gov","publication_date":"2026-10-01","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07852832","substance_tags":"psilocybin","topic_tags":"Addiction,Brain Imaging,Aging","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-10-02 01:26:31","last_checked":"2026-10-08 01:24:59","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07852832","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07852832","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07852832","source_url":"https://clinicaltrials.gov/study/NCT07852832","doi":"","pmid":"","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5953,"title":"ADEPT: Augmenting DBT Effectiveness With Psilocybin-Assisted Therapy","authors":"University of Minnesota","journal":"ClinicalTrials.gov","publication_date":"2026-09-22","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07833761","substance_tags":"psilocybin","topic_tags":"Depression,Personality Change,Emotional Processing,Mystical Experience,Safety,Adverse Events","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-09-23 01:38:32","last_checked":"2026-09-29 01:24:26","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07833761","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07833761","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07833761","source_url":"https://clinicaltrials.gov/study/NCT07833761","doi":"","pmid":"","publication_date":"2026-09-22","importer_version":"2.1.3","text_redistributed":false}},{"id":5935,"title":"Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial","authors":"University Health Network, Toronto","journal":"ClinicalTrials.gov","publication_date":"2026-09-15","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07820033","substance_tags":"psilocybin","topic_tags":"Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-09-16 01:36:54","last_checked":"2026-09-22 01:37:25","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07820033","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07820033","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07820033","source_url":"https://clinicaltrials.gov/study/NCT07820033","doi":"","pmid":"","publication_date":"2026-09-15","importer_version":"2.1.3","text_redistributed":false}},{"id":5931,"title":"A Phase 1b Study to Evaluate the Safety and Tolerability of MLS101 Treatment for Premenstrual Dysphoric Disorder (PMDD)","authors":"MycoMedica Life Sciences PBC","journal":"ClinicalTrials.gov","publication_date":"2026-09-14","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07818720","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-09-15 01:33:06","last_checked":"2026-09-21 01:21:54","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07818720","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07818720","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07818720","source_url":"https://clinicaltrials.gov/study/NCT07818720","doi":"","pmid":"","publication_date":"2026-09-14","importer_version":"2.1.3","text_redistributed":false}},{"id":5930,"title":"Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation","authors":"Brown University","journal":"ClinicalTrials.gov","publication_date":"2026-10-08","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07818564","substance_tags":"psilocybin","topic_tags":"Clinical Trial","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-09-15 01:33:06","last_checked":"2026-10-09 01:24:43","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07818564","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07818564","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07818564","source_url":"https://clinicaltrials.gov/study/NCT07818564","doi":"","pmid":"","publication_date":"2026-10-08","importer_version":"2.1.3","text_redistributed":false}},{"id":5893,"title":"Psilocybin-Assisted Psychotherapy for Posttraumatic Stress Disorder in Military Veterans: A Pilot Feasibility Study","authors":"ARQ National Psychotrauma Centre","journal":"ClinicalTrials.gov","publication_date":"2026-08-28","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07792538","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Emotional Processing,Psychological Flexibility,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Veterans,Safety","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-08-29 01:31:17","last_checked":"2026-09-04 01:26:15","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07792538","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07792538","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07792538","source_url":"https://clinicaltrials.gov/study/NCT07792538","doi":"","pmid":"","publication_date":"2026-08-28","importer_version":"2.1.3","text_redistributed":false}},{"id":5892,"title":"High vs. Low-Dose Group-Based Psilocybin-Assisted Therapy (PAT) With or Without Mindfulness-Based (MB) Preparation and Integration for Demoralization in Adults With Advanced Cancer (PAT-MIND): A Pilot Feasibility 2x2 Factorial Multisite Trial","authors":"University of Calgary","journal":"ClinicalTrials.gov","publication_date":"2026-09-02","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07791901","substance_tags":"psilocybin","topic_tags":"Biomarkers,Clinical Trial,Review Article,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-08-29 01:31:17","last_checked":"2026-09-09 01:28:52","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07791901","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07791901","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07791901","source_url":"https://clinicaltrials.gov/study/NCT07791901","doi":"","pmid":"","publication_date":"2026-09-02","importer_version":"2.1.3","text_redistributed":false}},{"id":5872,"title":"Psilocybin in the Treatment of Methamphetamine Use Disorder","authors":"Peter Hendricks","journal":"ClinicalTrials.gov","publication_date":"2026-09-21","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07774702","substance_tags":"psilocybin","topic_tags":"Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-08-20 01:29:20","last_checked":"2026-09-28 01:25:27","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07774702","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07774702","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07774702","source_url":"https://clinicaltrials.gov/study/NCT07774702","doi":"","pmid":"","publication_date":"2026-09-21","importer_version":"2.1.3","text_redistributed":false}},{"id":5852,"title":"Psilocybin Recovery Intervention for Stopping Methamphetamine Use","authors":"Nicky Mehtani, MD, MPH","journal":"ClinicalTrials.gov","publication_date":"2026-08-11","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07756736","substance_tags":"psilocybin","topic_tags":"Clinical Trial","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-08-12 01:27:30","last_checked":"2026-08-18 01:24:17","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07756736","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07756736","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07756736","source_url":"https://clinicaltrials.gov/study/NCT07756736","doi":"","pmid":"","publication_date":"2026-08-11","importer_version":"2.1.3","text_redistributed":false}},{"id":5846,"title":"Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies","authors":"University of New Mexico","journal":"ClinicalTrials.gov","publication_date":"2026-08-04","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07745569","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Brain Imaging,Aging,Emotional Processing,Observational Study,Safety,Transcriptomics","study_type":"Observational Study","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-08-09 10:12:43","last_checked":"2026-08-11 01:26:59","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07745569","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07745569","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07745569","source_url":"https://clinicaltrials.gov/study/NCT07745569","doi":"","pmid":"","publication_date":"2026-08-04","importer_version":"2.1.3","text_redistributed":false}},{"id":5845,"title":"The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease","authors":"Yale University","journal":"ClinicalTrials.gov","publication_date":"2026-09-28","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07610369","substance_tags":"psilocybin","topic_tags":"Depression,Microdosing,Randomized Controlled Trial,Safety","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-08-09 10:12:43","last_checked":"2026-10-05 01:24:30","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07610369","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07610369","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07610369","source_url":"https://clinicaltrials.gov/study/NCT07610369","doi":"","pmid":"","publication_date":"2026-09-28","importer_version":"2.1.3","text_redistributed":false}},{"id":5844,"title":"Psilocybin-assisted Cognitive Behavioral Therapy for Depression","authors":"University of California, Los Angeles","journal":"ClinicalTrials.gov","publication_date":"2026-05-19","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT05227612","substance_tags":"psilocybin","topic_tags":"Depression","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-08-09 10:12:42","last_checked":"2026-08-09 10:12:42","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT05227612","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT05227612","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT05227612","source_url":"https://clinicaltrials.gov/study/NCT05227612","doi":"","pmid":"","publication_date":"2026-05-19","importer_version":"2.1.3","text_redistributed":false}},{"id":5843,"title":"Psilocybin for Treatment of Obsessive Compulsive Disorder","authors":"University of Arizona","journal":"ClinicalTrials.gov","publication_date":"2024-08-30","publication_year":2024,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT03300947","substance_tags":"psilocybin","topic_tags":"Anxiety,OCD,Mechanism of Action","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-08-09 10:12:42","last_checked":"2026-08-09 10:12:42","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT03300947","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT03300947","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03300947","source_url":"https://clinicaltrials.gov/study/NCT03300947","doi":"","pmid":"","publication_date":"2024-08-30","importer_version":"2.1.3","text_redistributed":false}},{"id":5761,"title":"Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression","authors":"Joshua Rosenblat","journal":"ClinicalTrials.gov","publication_date":"2026-07-30","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07737990","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-31 01:27:07","last_checked":"2026-08-09 10:12:45","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07737990","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07737990","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07737990","source_url":"https://clinicaltrials.gov/study/NCT07737990","doi":"","pmid":"","publication_date":"2026-07-30","importer_version":"2.1.3","text_redistributed":false}},{"id":5760,"title":"Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for Post-Traumatic Stress Disorder","authors":"Tel-Aviv Sourasky Medical Center","journal":"ClinicalTrials.gov","publication_date":"2026-07-30","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07737054","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Emotional Processing,Psychological Flexibility,Clinical Trial,Randomized Controlled Trial,Healthcare Workers,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-31 01:27:07","last_checked":"2026-08-09 10:12:42","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07737054","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07737054","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07737054","source_url":"https://clinicaltrials.gov/study/NCT07737054","doi":"","pmid":"","publication_date":"2026-07-30","importer_version":"2.1.3","text_redistributed":false}},{"id":5755,"title":"Changes in Self-awareness Induced by Psychoactive Substances: an Experimental Study With Psilocybin.","authors":"Pontifícia Universidade Católica do Rio de Janeiro","journal":"ClinicalTrials.gov","publication_date":"2026-07-28","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07732166","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,OCD,Healthy Volunteers","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-29 01:27:13","last_checked":"2026-08-09 10:12:41","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07732166","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07732166","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07732166","source_url":"https://clinicaltrials.gov/study/NCT07732166","doi":"","pmid":"","publication_date":"2026-07-28","importer_version":"2.1.3","text_redistributed":false}},{"id":5746,"title":"Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease","authors":"National Institute on Aging (NIA)","journal":"ClinicalTrials.gov","publication_date":"2026-10-08","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07721467","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Biomarkers,Aging,Mitochondrial Function,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Older Adults,Safety,Adverse Events,Inflammation","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-24 01:25:24","last_checked":"2026-10-09 01:24:43","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07721467","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07721467","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07721467","source_url":"https://clinicaltrials.gov/study/NCT07721467","doi":"","pmid":"","publication_date":"2026-10-08","importer_version":"2.1.3","text_redistributed":false}},{"id":5742,"title":"An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life","authors":"Charles Raison","journal":"ClinicalTrials.gov","publication_date":"2026-08-17","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07719088","substance_tags":"psilocybin,psilocin","topic_tags":"Neuroplasticity,Mechanism of Action,Biomarkers,Aging,Epigenetics,Cellular Senescence,Longevity,Oxidative Stress,Wellbeing,Clinical Trial,Observational Study,Animal Study,Older Adults,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-23 01:25:56","last_checked":"2026-08-24 01:23:39","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07719088","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07719088","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07719088","source_url":"https://clinicaltrials.gov/study/NCT07719088","doi":"","pmid":"","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5731,"title":"A Randomized, Double-Blind, Single Ascending Dose Study to Identify a Safe and Non-Psychedelic Dose of Psilocybin","authors":"Diamond Therapeutics Inc.","journal":"ClinicalTrials.gov","publication_date":"2026-07-17","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07710027","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Biomarkers,Review Article,Observational Study,Healthy Volunteers,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-18 01:24:24","last_checked":"2026-08-09 10:12:42","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07710027","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07710027","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07710027","source_url":"https://clinicaltrials.gov/study/NCT07710027","doi":"","pmid":"","publication_date":"2026-07-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5722,"title":"Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Trauma-Related Major Depressive Disorder: Randomized Controlled Trial","authors":"Khyber Medical University Peshawar","journal":"ClinicalTrials.gov","publication_date":"2026-07-14","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07703722","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Biomarkers,Emotional Processing,Randomized Controlled Trial,Microbiome,Inflammation,Immune Function","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-15 01:27:00","last_checked":"2026-08-09 10:12:41","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07703722","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07703722","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07703722","source_url":"https://clinicaltrials.gov/study/NCT07703722","doi":"","pmid":"","publication_date":"2026-07-14","importer_version":"2.1.3","text_redistributed":false}}],"total":308,"page":1,"per_page":20,"pages":16,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"ClinicalTrials.gov","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}